Index RUT P/E - EPS (ttm) -1.75 Insider Own 24.60% Shs Outstand 172.63M Perf Week 8.10%
Market Cap 1.53B Forward P/E - EPS next Y -1.67 Insider Trans -0.58% Shs Float 130.68M Perf Month 10.96%
Enterprise Value 963.87M PEG - EPS next Q -0.40 Inst Own 75.47% Short Float 18.38% Perf Quarter 40.06%
Income -297.59M P/S 182.65 EPS this Y 26.63% Inst Trans -4.50% Short Ratio 10.55 Perf Half Y 157.60%
Sales 8.36M P/B 2.50 EPS next Y 3.48% ROA -37.20% Short Interest 24.03M Perf YTD 4.14%
Book/sh 3.52 P/C 2.56 EPS next 5Y 10.68% ROE -41.14% 52W High 9.24 -4.71% Perf Year 134.31%
Cash/sh 3.44 P/FCF - EPS past 3/5Y 14.82% -23.05% ROIC -46.69% 52W Low 1.77 396.34% Perf 3Y -54.96%
Dividend Est. - EV/EBITDA - Sales past 3/5Y 48.94% -Gross Margin 48.64% Volatility 8.87% 8.10% Perf 5Y -80.81%
Dividend TTM - EV/Sales 115.30 EPS Y/Y TTM 33.02% Oper. Margin -3914.38% ATR (14) 0.64 Perf 10Y -
Dividend Ex-Date - Quick Ratio 19.14 Sales Y/Y TTM -16.50% Profit Margin -3561.43% RSI (14) 57.09 Recom 1.08
Dividend Gr. 3/5Y - - Current Ratio 19.14 EPS Q/Q 31.55% SMA20 8.73% Beta 1.60 Target Price 15.09
Payout - Debt/Eq 0.05 Sales Q/Q - SMA50 8.84% Rel Volume 0.97 Prev Close 9.15
Employees 261 LT Debt/Eq 0.05 Earnings Nov 06 AMC SMA200 64.66% Avg Volume 2.28M Price 8.81
IPO Jul 16, 2020 Option/Short Yes / Yes EPS/Sales Surpr. -3.54% -100.00% Trades
Volume 2,218,023 Change -3.72%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-26-26 Upgrade Oppenheimer
Perform → Outperform
$14
Dec-12-25 Upgrade Wells Fargo
Equal Weight → Overweight
$13
Sep-04-25 Resumed Guggenheim
Buy
$15
Apr-17-25 Initiated Wells Fargo
Equal Weight
$4
Sep-10-24 Upgrade Jefferies
Hold → Buy
$10.60 → $16
Sep-10-24 Resumed Goldman
Buy
$20
Sep-10-24 Downgrade Oppenheimer
Outperform → Perform
May-10-24 Upgrade Barclays
Equal Weight → Overweight
$15
Apr-20-23 Upgrade Jefferies
Underperform → Hold
$12.50
Apr-19-23 Upgrade Raymond James
Outperform → Strong Buy
$29
Apr-13-23 Initiated Raymond James
Outperform
$29
Feb-03-23 Initiated Oppenheimer
Outperform
$33
Sep-30-22 Initiated Barclays
Equal Weight
$23
Sep-02-22 Initiated Stifel
Buy
$40
Jun-06-22 Initiated Jefferies
Underperform
$13
Feb-01-22 Initiated Berenberg
Buy
$45
Jul-21-21 Initiated BofA Securities
Buy
$50
Dec-15-20 Reiterated H.C. Wainwright
Buy
$54 → $57
Dec-08-20 Initiated JMP Securities
Mkt Outperform
$66
Nov-05-20 Initiated H.C. Wainwright
Buy
$54
Show Previous Ratings
Feb-05-26 09:35AM
Feb-04-26 04:05PM
06:27AM
(Pharmaceutical Business Review)
Feb-03-26 07:00AM
Feb-02-26 09:51AM
07:00AM
Loading…
Dec-12-25 07:00AM
Nov-11-25 10:10AM
09:56AM
Nov-06-25 04:05PM
Nov-03-25 04:05PM
Oct-30-25 04:05PM
09:55AM
Oct-28-25 12:00PM
11:35AM
Oct-14-25 09:55AM
09:25AM
Loading…
Sep-21-25 09:25AM
Sep-08-25 09:42AM
12:30AM
Sep-05-25 06:42PM
Aug-28-25 04:05PM
Aug-25-25 11:56PM
Aug-17-25 11:41PM
Aug-12-25 12:00PM
Aug-07-25 06:35PM
04:05PM
Aug-04-25 10:01AM
Jul-31-25 04:05PM
Jul-29-25 09:56AM
Jul-25-25 11:33AM
Jul-23-25 10:02AM
09:58AM
Loading…
Jul-16-25 09:58AM
Jul-07-25 10:23AM
Jul-02-25 10:28AM
Jun-24-25 03:51PM
Jun-20-25 09:21AM
Jun-11-25 04:05PM
Jun-09-25 11:37AM
Jun-02-25 07:00AM
May-29-25 04:05PM
May-27-25 09:45AM
May-23-25 12:00PM
May-13-25 08:49AM
May-08-25 04:05PM
May-07-25 06:58PM
May-05-25 04:05PM
Apr-28-25 04:05PM
Apr-20-25 06:19AM
Apr-16-25 10:03AM
09:45AM
Apr-12-25 09:28AM
Apr-09-25 09:44AM
05:00AM
Mar-31-25 09:56AM
Mar-05-25 09:35AM
Feb-26-25 04:05PM
Feb-25-25 10:48AM
Feb-24-25 04:05PM
Feb-19-25 04:05PM
Jan-24-25 12:09PM
Jan-07-25 04:05PM
Dec-30-24 02:57PM
Dec-20-24 12:00PM
Dec-13-24 05:49PM
Dec-11-24 06:00AM
Dec-09-24 04:05PM
Dec-06-24 09:35AM
Dec-05-24 06:51AM
Dec-04-24 04:36PM
Dec-03-24 08:01AM
08:00AM
Nov-20-24 09:35AM
Nov-19-24 09:35AM
Nov-07-24 04:05PM
Nov-06-24 04:05PM
Oct-30-24 04:05PM
Sep-17-24 08:24AM
Sep-11-24 06:46PM
Sep-10-24 08:21PM
Sep-09-24 04:34PM
11:30AM
08:07AM
06:55AM
Sep-06-24 04:05PM
Aug-06-24 04:05PM
Jul-30-24 04:05PM
Jul-17-24 07:45AM
Jun-06-24 07:00AM
Jun-05-24 04:05PM
May-21-24 04:05PM
May-13-24 08:30AM
May-10-24 10:01AM
May-06-24 08:57AM
May-02-24 09:55PM
05:55PM
05:40PM
04:05PM
Apr-25-24 04:05PM
Apr-11-24 04:05PM
Mar-17-24 05:20PM
Mar-15-24 12:39PM
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bergstrom Donald A President, R&D Jan 27 '26 Sale 7.62 18,895 143,980 422,733 Jan 29 04:22 PM Bergstrom Donald A President, R&D Jan 28 '26 Sale 8.45 2,686 22,697 420,047 Jan 29 04:22 PM Rahmer Peter See remarks Jan 27 '26 Sale 7.62 11,684 89,032 277,964 Jan 29 04:22 PM Rahmer Peter See remarks Jan 28 '26 Sale 8.45 1,354 11,441 276,610 Jan 29 04:22 PM Catinazzo Thomas Chief Financial Officer Jan 27 '26 Sale 7.62 13,820 105,308 250,996 Jan 29 04:20 PM Catinazzo Thomas Chief Financial Officer Jan 28 '26 Sale 8.45 1,695 14,323 249,301 Jan 29 04:20 PM Patel Sanjiv President and CEO Jan 06 '26 Sale 7.82 43,168 337,574 661,041 Jan 07 04:15 PM Patel Sanjiv President and CEO Nov 03 '25 Sale 7.00 62,073 434,511 703,215 Nov 04 04:10 PM Rahmer Peter See remarks Oct 29 '25 Sale 7.50 21,394 160,455 337,469 Oct 30 04:19 PM Rahmer Peter See remarks Oct 28 '25 Sale 7.29 19,135 139,494 358,863 Oct 30 04:19 PM Catinazzo Thomas Chief Financial Officer Oct 28 '25 Sale 7.29 21,664 157,931 313,631 Oct 30 04:15 PM Bergstrom Donald A President, R&D Oct 28 '25 Sale 7.29 30,897 225,239 521,823 Oct 30 04:12 PM Peter J Rahmer Officer Oct 29 '25 Proposed Sale 7.50 21,394 160,436 Oct 29 04:18 PM Rahmer Peter See remarks Jul 29 '25 Sale 3.68 15,724 57,864 377,998 Jul 30 04:54 PM Rahmer Peter See remarks Jul 28 '25 Sale 3.74 1,359 5,083 393,722 Jul 30 04:54 PM Catinazzo Thomas Chief Financial Officer Jul 29 '25 Sale 3.68 18,380 67,638 335,295 Jul 30 04:54 PM Catinazzo Thomas Chief Financial Officer Jul 28 '25 Sale 3.74 1,701 6,362 353,675 Jul 30 04:54 PM Bergstrom Donald A President, R&D Jul 29 '25 Sale 3.68 26,701 98,260 552,720 Jul 30 04:54 PM Bergstrom Donald A President, R&D Jul 28 '25 Sale 3.74 4,069 15,218 579,421 Jul 30 04:54 PM Adams Brian Chief Legal Officer Jul 29 '25 Sale 3.68 18,276 67,256 371,472 Jul 30 04:53 PM Adams Brian Chief Legal Officer Jul 28 '25 Sale 3.74 1,637 6,122 389,748 Jul 30 04:53 PM Patel Sanjiv President and CEO Jul 09 '25 Sale 3.57 61,379 219,123 765,288 Jul 10 04:55 PM Rahmer Peter See remarks Apr 30 '25 Sale 3.00 10,739 32,217 390,081 Apr 30 08:25 PM Rahmer Peter See remarks Apr 28 '25 Sale 3.17 1,364 4,324 400,820 Apr 30 08:25 PM Catinazzo Thomas Chief Financial Officer Apr 30 '25 Sale 3.00 12,943 38,829 355,376 Apr 30 08:24 PM Catinazzo Thomas Chief Financial Officer Apr 29 '25 Sale 3.23 3,558 11,492 368,319 Apr 30 08:24 PM Catinazzo Thomas Chief Financial Officer Apr 28 '25 Sale 3.17 2,690 8,527 371,877 Apr 30 08:24 PM Bergstrom Donald A President, R&D Apr 30 '25 Sale 3.00 27,472 82,416 583,490 Apr 30 08:24 PM Bergstrom Donald A President, R&D Apr 28 '25 Sale 3.17 4,090 12,965 610,962 Apr 30 08:24 PM Adams Brian Chief Legal Officer Apr 30 '25 Sale 3.00 12,943 38,829 391,385 Apr 30 08:23 PM Adams Brian Chief Legal Officer Apr 28 '25 Sale 3.17 1,644 5,211 404,328 Apr 30 08:23 PM THOMAS J CATINAZZO Officer Apr 29 '25 Proposed Sale 3.23 3,558 11,492 Apr 29 04:01 PM THOMAS J CATINAZZO Officer Apr 28 '25 Proposed Sale 3.17 981 3,110 Apr 28 04:02 PM Patel Sanjiv President and CEO Apr 23 '25 Sale 2.97 61,422 182,423 821,667 Apr 24 04:03 PM Bergstrom Donald A President, R&D Mar 27 '25 Sale 2.84 986 2,800 615,052 Mar 31 04:19 PM Rahmer Peter See remarks Mar 27 '25 Sale 2.84 247 701 402,184 Mar 31 04:15 PM Catinazzo Thomas Chief Financial Officer Mar 27 '25 Sale 2.84 4,864 13,814 374,567 Mar 31 04:13 PM Adams Brian Chief Legal Officer Mar 27 '25 Sale 2.84 298 846 405,972 Mar 31 04:12 PM THOMAS J CATINAZZO Officer Mar 27 '25 Proposed Sale 2.84 4,566 12,967 Mar 27 04:03 PM
